Finally the BUM is out. This is the final chapter in stock's slide. We are going up from here. It seem the company is getting ready for a buy out. The wording of the PR about TRANSFER of knowledge from current employees almost ALWAYS relates to a pending buy out.
Sentiment: Strong Buy
Because they gave the drug to Takeda, this firm is here to clean house and get things in shape for a proper buyout. The royalties were a joke, look at the level 2 as well with Edge controlling price and accumulating shares. They have started the process of getting the PPS to a normal level so there is something good left to sell.
With the retention of TBG in connection with the restructuring, the Company plans to terminate the employment of the remaining named executive officers, John Orwin and Herb Cross, no later than June 15, 2013